FMI analysis suggests that the future growth of the autism diagnostics market is no longer tied to clinical discovery alone, but to reimbursement maturation. The research report on autism diagnostics states that as AI-driven diagnostic software secures Medicaid and private payer coverage, the autism diagnostics market will shift from specialized hospital settings into primary care and home-based environments. FMI views the autism diagnostics market as a sector poised for